Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement
复制标题
DOI：
10.7326/0003-4819-157-2-201207170-00459
复制
发表时间：
2012-07-17
影响因子：
39.2
通讯作者：
Moyer, Virginia A.
中科院分区：
文献类型：
--
作者：
Moyer, Virginia A.
描述：更新2008年美国预防服务工作组（USPSTF）关于前列腺癌筛查的建议声明。方法：USPSTF回顾了基于前列腺特异性抗原（PSA）筛查前列腺癌的利与弊的新证据，以及局部前列腺癌治疗的利与弊。推荐：USPSTF不推荐基于psa的前列腺癌筛查（D级推荐）。这一建议适用于所有美国男性，不论年龄大小。本建议不包括在诊断或治疗前列腺癌后使用PSA检测进行监测；该适应症的PSA检测的使用超出了USPSTF的范围。
Description: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for prostate cancer.Methods: The USPSTF reviewed new evidence on the benefits and harms of prostate-specific antigen (PSA)-based screening for prostate cancer, as well as the benefits and harms of treatment of localized prostate cancer.Recommendation: The USPSTF recommends against PSA-based screening for prostate cancer (grade D recommendation).This recommendation applies to men in the general U.S. population, regardless of age. This recommendation does not include the use of the PSA test for surveillance after diagnosis or treatment of prostate cancer; the use of the PSA test for this indication is outside the scope of the USPSTF.